Literature DB >> 12176556

Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.

K Uchida1, Y Tominaga, T Haba, T Katayama, S Matsuoka, T Sato, N Goto, A Takeda, K Morozumi, H Takagi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12176556     DOI： 10.1016/s0041-1345(02)03002-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.

Authors:  Agnieszka A Prytuła; Karlien Cransberg; Antonia H M Bouts; Ron H N van Schaik; Huib de Jong; Saskia N de Wildt; Ron A A Mathôt
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

3.  Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants.

Authors:  Seung Seok Han; Do Hyoung Kim; Su Mi Lee; Na Young Han; Jung Mi Oh; Jongwon Ha; Yon Su Kim
Journal:  Kidney Res Clin Pract       Date:  2012-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.